Seeing Is Believing
LOGC is currently covered by 2 analysts with an average price target of $5.19. This is a potential upside of $5.19 (0%) from yesterday's end of day stock price of $0.
LogicBio Therapeutics's activity chart (see below) currently has 3 price targets and 6 ratings on display. The stock rating distribution of LOGC is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 8.33% with an average time for these price targets to be met of 36.5 days.
Highest price target for LOGC is $1, Lowest price target is $1, average price target is $5.19.
Most recent stock forecast was given by SILVAN TUERKCAN from JMP on 10-May-2022.
Currently out of the existing stock ratings of LOGC, 2 are a BUY (100%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
2
$-0.07 (-3.38%)
16
1 years 10 months 18 days ago
1/3 (33.33%)
$1.54 (334.78%)
146
Buy
8
$5.93 (286.47%)
2 years 4 months 11 days ago
0/1 (0%)
$4.53 (130.55%)
Buy
26
$23.93 (1156.04%)
26
4 years 2 months 18 days ago
0/3 (0%)
$14.67 (150.78%)
What is LOGC (LogicBio Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on LOGC (LogicBio Therapeutics) with a proven track record?
Which analyst has the current lower performing score on LOGC (LogicBio Therapeutics) with a proven track record?
Which analyst has the most public recommendations on LOGC (LogicBio Therapeutics)?
Which analyst is the currently most bullish on LOGC (LogicBio Therapeutics)?
Which analyst is the currently most reserved on LOGC (LogicBio Therapeutics)?